Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UnitedHealth Group Incorporated (UNH) provides extensive disclosure to investors and regulators through its SEC filings, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents offer a detailed view of the company’s health care and well-being operations, which span UnitedHealthcare’s health benefit programs and Optum’s health services, technology and analytics businesses.
Annual and quarterly reports describe UnitedHealth Group’s consolidated financial condition and results of operations, as well as segment performance for UnitedHealthcare and Optum. They include information on revenues, earnings from operations, medical costs, operating costs, cash flows, capital structure and risk factors. Investors use these filings to understand how trends in medical utilization, Medicare and Medicaid funding, and pharmacy services affect the company’s financial profile.
Current reports on Form 8-K provide timely updates on material events. Recent 8-K filings have covered topics such as quarterly earnings releases, reaffirmation of earnings outlooks, amendments to bylaws to reflect changes in the company’s registered office and registered agent in Delaware, the appointment of new independent directors, and investor presentations. Some 8-K items are furnished under Regulation FD to share information discussed with investors and analysts, including earnings expectations and the impact of acquisitions like Amedisys.
UnitedHealth Group also files 8-Ks to document governance and leadership changes, including the appointment of directors with regulatory and clinical backgrounds. These filings often reference standard indemnification agreements and compensation arrangements for non-employee directors, providing additional transparency into board practices.
On this SEC filings page, users can review UnitedHealth Group’s regulatory disclosures in one place. Real-time updates from EDGAR ensure that new 10-K, 10-Q and 8-K filings, as well as any amendments, appear promptly. AI-powered summaries can help explain complex sections, highlight key metrics, and clarify the implications of items such as changes in outlook, medical cost trends or bylaw amendments. Investors can also monitor executive and director changes reported on Form 8-K and use the filings history to track how UnitedHealth Group’s strategy, capital management and risk profile evolve over time.
HOOPER MICHELE J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Michele J. Hooper received a grant of 206 deferred stock units of common stock on April 1, 2026 as regular quarterly compensation for Board service. The units are immediately vested but must be held until her Board service ends, bringing her direct holdings to 41,792 shares/units. This is a routine compensation-related equity award rather than an open-market purchase or sale.
MCNABB FREDERICK WILLIAM III reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant of 388 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until he completes his service on the Board, and his direct holdings after the award total 15,162 shares.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 343 deferred stock units of Common Stock as part of his regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 2,163 shares.
Gil Kristen reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Kristen Gil received 320 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until her Board service ends. Following this grant, she holds 2,403 shares directly and 3,800 shares indirectly through a trust.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
Director John H. Noseworthy received a grant of 320 deferred stock units of UnitedHealth Group common stock as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board. Following this award, he directly holds 7,369 shares of common stock.
UnitedHealth Group director Paul R. Garcia reported routine equity compensation awards. On April 1, 2026, he acquired 206 deferred stock units and 137 shares of common stock as regular quarterly compensation for Board service. The deferred stock units are immediately vested but must be held until he completes Board service.
After these awards, Garcia directly holds 3,673 shares of UnitedHealth Group common stock. He also has indirect holdings through trusts, including 2,146 shares by a revocable trust, 45 shares by Trust 2, and 55 shares by Trust 3, reflecting additional beneficial interests reported in this filing.
Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Scott Gottlieb received a grant of 320 deferred stock units of Common Stock as regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board. Following this award, he directly holds 446 shares/units in total.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice, MD, received an award of 343 deferred stock units of common stock as regular quarterly compensation for Board service. The units are immediately vested but must be held until she completes her Board service. Following this grant, she directly holds 7,615 shares/units.
FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Timothy Patrick Flynn received a grant of 350 shares of Common Stock-equivalent deferred stock units on April 1 as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board.
Following this grant, Flynn directly holds 10,589 shares of UnitedHealth Group common stock. In addition, an indirect holding entry reflects 6,033 shares held by a trust, indicating a separate ownership structure for part of his overall position.
UnitedHealth Group Inc ownership disclosure: The Vanguard Group filed Amendment No. 11 to its Schedule 13G/A reporting that it beneficially owns 0 shares of Common Stock, representing 0%. The filing states this result follows an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 (January 12, 1998), and that certain Vanguard subsidiaries now report holdings separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.